CVS Health Stock-Based Comp increased by 97.0% to $266.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 111.1%, from $126.00M to $266.00M. Over 4 years (FY 2021 to FY 2025), Stock-Based Comp shows an upward trend with a 2.5% CAGR.
An increase may signal a strategy to preserve cash or align employee interests with shareholders, but it also results in share dilution.
Stock-based compensation is a non-cash expense where employees and executives are rewarded with equity or stock options...
High-growth technology firms often have higher stock-based compensation as a percentage of revenue compared to mature industrial firms.
cf_stock_based_compensation| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $145.00M | $114.00M | $138.00M | $89.00M | $147.00M | $105.00M | $106.00M | $103.00M | $204.00M | $154.00M | $127.00M | $137.00M | $133.00M | $133.00M | $137.00M | $126.00M | $136.00M | $138.00M | $135.00M | $266.00M |
| QoQ Change | — | -21.4% | +21.1% | -35.5% | +65.2% | -28.6% | +1.0% | -2.8% | +98.1% | -24.5% | -17.5% | +7.9% | -2.9% | +0.0% | +3.0% | -8.0% | +7.9% | +1.5% | -2.2% | +97.0% |
| YoY Change | — | — | — | — | +1.4% | -7.9% | -23.2% | +15.7% | +38.8% | +46.7% | +19.8% | +33.0% | -34.8% | -13.6% | +7.9% | -8.0% | +2.3% | +3.8% | -1.5% | +111.1% |